Ming Ni
Impact in
- Oncology top 10%
- Saffron Plant Research Studies
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
-
- Phytochemical and Pharmacological Studies
Papers in
- Oncology 7
- Cancer Treatment and Pharmacology 4
- Colorectal Cancer Treatments and Studies 3
-
- Ocular Diseases and Behçet’s Syndrome 4
- Glaucoma and retinal disorders 2
- Retinal Diseases and Treatments 2
- Co-authors
- Anna Fishbein (2 shared papers)Jing Xie (1 shared paper)Han Aung (1 shared paper)Sangeeta R. Mehendale (1 shared paper)Chun‐Su Yuan (1 shared paper)Bruce Charles (4 shared papers)John A. Duley (4 shared papers)Ross Norris (4 shared papers)
- Journals
- Experimental Eye Research (1 paper)Clinical Cancer Research (1 paper)The FASEB Journal (1 paper)Therapeutic Drug Monitoring (1 paper)Journal of Liposome Research (1 paper)
- Partner nations
- United StatesAustraliaChina
In The Last Decade
Ming Ni
18 papers receiving 425 citations
Peers
Comparison fields: 5 of 65
- Oncology 229
- Complementary and alternative medicine 37
- Ophthalmology 38
- Pharmacology 68
- Pharmacology 24
Countries citing papers authored by Ming Ni
This map shows the geographic impact of Ming Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Ni more than expected).
Fields of papers citing papers by Ming Ni
This network shows the impact of papers produced by Ming Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Ni. The network helps show where Ming Ni may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Ni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells. | 2007 | 176 |
| 2 | 2017 | 64 | |
| 3 | 2011 | 47 | |
| 4 | 2020 | 22 | |
| 5 | 1988 | 21 | |
| 6 | 2015 | 19 | |
| 7 | 2009 | 17 | |
| 8 | 2005 | 15 | |
| 9 | 1990 | 15 | |
| 10 | 1991 | 11 | |
| 11 | 2013 | 9 | |
| 12 | 1992 | 9 | |
| 13 | 2016 | 8 | |
| 14 | 2018 | 2 | |
| 15 | 1989 | 2 | |
| 16 | Distribution of Newly Formed Retinal Pigment Epithelium (RPE) Related Cells in Rabbit Choroidal Neovascularization (CNV) | 2003 | 1 |
| 17 | 2005 | 1 | |
| 18 | 1998 | 1 | |
| 19 | 2023 | 0 |
About Ming Ni
Ming Ni is a scholar working on Oncology, Ophthalmology, Molecular Biology, Pharmacology and Cancer Research, having authored 19 papers that have together received 440 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Ocular Diseases and Behçet’s Syndrome (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Inflammatory mediators and NSAID effects (2 papers), Glaucoma and retinal disorders (2 papers), Systemic Lupus Erythematosus Research (2 papers), Cytomegalovirus and herpesvirus research (2 papers) and Retinal Diseases and Treatments (2 papers). The work is most often cited by research in Oncology (229 citations), Complementary and alternative medicine (37 citations), Ophthalmology (38 citations), Pharmacology (68 citations) and Pharmacology (24 citations). Ming Ni has collaborated with scholars based in United States, Australia and China. Frequent co-authors include Anna Fishbein, Jing Xie, Han Aung, Sangeeta R. Mehendale, Chun‐Su Yuan, Bruce Charles, John A. Duley, Ross Norris, Robert B. Nussenblatt and Andrew S. Moore. Their work appears in journals such as Experimental Eye Research, Clinical Cancer Research, The FASEB Journal, Therapeutic Drug Monitoring and Journal of Liposome Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.